What Researchers Did
The researchers looked at the records of 75 people with a blocked artery in the eye (branch or central retinal artery occlusion) and compared eye and stroke outcomes between those who received hyperbaric oxygen therapy (HBOT) and those who did not.
What They Found
In this single-institution study of 75 people with retinal artery occlusion, HBOT was not linked to a significant change in vision or in later stroke or neovascular glaucoma. Twenty-seven people (36%) received HBOT when they first came in. Vision did not change from the first visit to the final timepoint in either group. For central occlusion, vision scores were 2.1 versus 2.2 without HBOT (p=0.755) and 2.1 versus 2.0 with HBOT (p=0.631). For branch occlusion, they were 0.4 versus 0.6 without HBOT (p=0.658) and 0.1 versus 0.4 with HBOT (p=0.207). Seven people (9.3%) had a stroke and five (6.7%) developed neovascular glaucoma, with no significant differences between the groups.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This was a single-institution study that compared people who did and did not receive HBOT without random assignment, and the abstract reports no significant differences in any outcome, so it cannot show that HBOT has no effect in every patient.